conference logo
 
Programme  Titles  Presenters  Topics 
SESSION 6 (continued): Genomics and Molecular Advances in Meningioma
Saturday, June 18, 2016, 10:10am - 11:10am

 

PANEL DISCUSSION: Kenneth Aldape, Priscilla Brastianos, Houtan Noushmehr

 


Histopathological prognostic factors of recurrence following surgery and radiation therapy for atypical and malignant meningiomas
Daniel Kim, Andrzej Niemierko, William L. Hwang, Anat O. Stemmer-Rachamimov, William T. Curry, Fred G. Barker, II, Robert L. Martuza, Kevin S. Oh, Jay S. Loeffler, Helen A. Shih*
Massachusetts General Hospital, Radiation Oncology, USA
10:10am
Global loss of histone H3K27 trimethylation in atypical and anaplastic meningiomas
Leah Katz*, Rajeev Sen, Girish Fatterpekar, Joshua Silverman, John Golfinos, Chandra Sen, David Zagzag, Matija Snuderl
NYU Langone Medical Center, USA
10:20am
microRNA-181d as biomarker in meningiomas progression
Vinicius Carneiro, Andressa Rodrigues*, Marcella Rosa, Luciano Neder, Daniela Tirapelli, Benedicto Colli, Carlos Carlotti
Ribeirao Preto Medical School, University of São Paulo, Brazil
10:30am
Epigenetic profiling and mathematical modeling reveals CpG hypermethylation phenotypes associated with recurrence-free survival in meningioma
Adriana Olar*1, Khalida M. Wani2, Charmaine D. Wilson3, Gelareh Zadeh4, Franco DeMonte5, David Jones6, Stefan Pfister6, Andreas von Deimling6, Erik P. Sulman2,7, Kenneth D. Aldape8
1MD Anderson Cancer Center, Hematopathology, USA, 2MD Anderson Cancer Center, Translational Molecular Pathology, USA, 3UT School of Nursing, Center for Nursing Research, USA, 4University of Toronto, Neurosurgery, Canada, 5MD Anderson Cancer Center, USA, 6German Cancer Research Center, Germany, 7MD Anderson Cancer Center, Radiation Oncology, USA, 8MacFeeters-Hamilton Brain Tumor Center and Princess Margaret Cancer Center, Canada